Tokyo, February 2, 2022 -- Genesis Healthcare Co., Japan's leading genetic testing and research company, today announced its laboratory, Genesis Institute of Genetic Research has been awarded accreditation by the College of American Pathologists (CAP).
In addition of being a registered clinical laboratory in Japan, the Genesis Institute for Genetic Research was recently inspected by the Accreditation Committee of the College of American Pathologists as part of the CAP’ accreditation program. Genesis Institute for Genetic Research is proud to be a CAP accredited laboratory and aspires to provide the highest precision and accuracy for clinical genetic testing to the Japanese medical community.
About the College of American Pathologists
For more information, visit www.cap.org
About Genesis Healthcare Co.
Genesis Healthcare Co. is a leading biotech company, pioneering genetic research since 2004 and conducted over 1,300,000 genetic tests to date. Leveraging more than 18 years of genetic research and development, Genesis Healthcare empowers medical institutions and end consumers alike to evolve towards personalized medicine and wellness.
For press and media inquiries, please contact:
Email: press@genesis-healthcare.jpo.